87 related articles for article (PubMed ID: 22983837)
1. Cost effectiveness of new breast cancer radiotherapy technologies in diverse populations.
Gold HT; Hayes MK
Breast Cancer Res Treat; 2012 Nov; 136(1):221-9. PubMed ID: 22983837
[TBL] [Abstract][Full Text] [Related]
2. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer.
Suh WW; Pierce LJ; Vicini FA; Hayman JA
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):790-6. PubMed ID: 15936561
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast.
Suh WW; Hillner BE; Pierce LJ; Hayman JA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1054-61. PubMed ID: 15752884
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy confined to the tumor bed following breast conserving surgery current status, controversies, and future projects.
Polgár C; Fodor J; Major T; Takácsi-Nagy Z; Kásler M; Hammer J; Van Limbergen E; Németh G
Strahlenther Onkol; 2002 Nov; 178(11):597-606. PubMed ID: 12426670
[TBL] [Abstract][Full Text] [Related]
5. Cost comparison of radiation treatment options after lumpectomy for breast cancer.
Greenup RA; Camp MS; Taghian AG; Buckley J; Coopey SB; Gadd M; Hughes K; Specht M; Smith BL
Ann Surg Oncol; 2012 Oct; 19(10):3275-81. PubMed ID: 22851048
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of radiotherapy for early breast cancer after breast-conserving surgery in a health resource-limited setting.
Bai Y; Ye M; Cao H; Ma X; Xu Y; Wu B
Breast Cancer Res Treat; 2012 Nov; 136(2):547-57. PubMed ID: 23053654
[TBL] [Abstract][Full Text] [Related]
8. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer.
Alvarado MD; Mohan AJ; Esserman LJ; Park CC; Harrison BL; Howe RJ; Thorsen C; Ozanne EM
Ann Surg Oncol; 2013 Sep; 20(9):2873-80. PubMed ID: 23812769
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2-positive breast cancer.
Liberato NL; Marchetti M; Barosi G
J Clin Oncol; 2007 Feb; 25(6):625-33. PubMed ID: 17308267
[TBL] [Abstract][Full Text] [Related]
11. Health economics of targeted intraoperative radiotherapy (TARGIT-IORT) for early breast cancer: a cost-effectiveness analysis in the United Kingdom.
Vaidya A; Vaidya P; Both B; Brew-Graves C; Bulsara M; Vaidya JS
BMJ Open; 2017 Aug; 7(8):e014944. PubMed ID: 28819067
[TBL] [Abstract][Full Text] [Related]
12. Cost-efficacy of acceleration partial-breast irradiation compared with whole-breast irradiation.
Shah C; Lanni TB; Saini H; Nanavati A; Wilkinson JB; Badiyan S; Vicini F
Breast Cancer Res Treat; 2013 Feb; 138(1):127-35. PubMed ID: 23329353
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
14. Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis.
Sher DJ; Wittenberg E; Suh WW; Taghian AG; Punglia RS
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):440-6. PubMed ID: 18963542
[TBL] [Abstract][Full Text] [Related]
15. A cost comparison analysis of adjuvant radiation therapy techniques after breast-conserving surgery.
Lanni T; Keisch M; Shah C; Wobb J; Kestin L; Vicini F
Breast J; 2013; 19(2):162-7. PubMed ID: 23294184
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of letrozole in the extended adjuvant treatment of women with early breast cancer.
El Ouagari K; Karnon J; Delea T; Talbot W; Brandman J
Breast Cancer Res Treat; 2007 Jan; 101(1):37-49. PubMed ID: 16821085
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Sofrygin O; Thomas SK; Papo NL; Barghout V
Clin Breast Cancer; 2007 Jun; 7(8):608-18. PubMed ID: 17592673
[TBL] [Abstract][Full Text] [Related]
18. Incorporating margin status information in treatment decisions for women with ductal carcinoma in situ: a decision analysis.
Wang SY; Kuntz K; Tuttle T; Kane R
Breast Cancer Res Treat; 2010 Nov; 124(2):393-402. PubMed ID: 20848183
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial.
Feldman AM; de Lissovoy G; Bristow MR; Saxon LA; De Marco T; Kass DA; Boehmer J; Singh S; Whellan DJ; Carson P; Boscoe A; Baker TM; Gunderman MR
J Am Coll Cardiol; 2005 Dec; 46(12):2311-21. PubMed ID: 16360064
[TBL] [Abstract][Full Text] [Related]
20. A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer.
Kurian AW; Thompson RN; Gaw AF; Arai S; Ortiz R; Garber AM
J Clin Oncol; 2007 Feb; 25(6):634-41. PubMed ID: 17308268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]